For over 25 years Mark has been active in the Life Science industry. After starting in academic research in Cambridge, Mark has gone on to build a career in Life science investment and M&A Advisory.
As an active Life Science investor Mark was active as a Principal at Inventages in both Switzerland & London as well as at the DEWB Venture Capital in Jena, Germany during which time he managed numerous investments and took positions on the boards or took up board observer rights on the vast majority. His experience spans across the investment cycle, from sourcing through investment negotiation, hands-on portfolio management driving towards exit negotiation.
Additionally Mark was a member of the Corporate Finance M&A Life Science sector team at BDO in London where he was a core member of the team and worked with clients especially in the out sourced pharma services and medical devices sectors.
The appointment of Mark will enable PharmaVentures to strengthen our cross-border M&A and fundraising capabilities